Israel Frederic. Charo

Israel Frederic. Charo's AcademicInfluence.com Rankings

Philosophy

#6728

World Rank

#9818

Historical Rank

Logic

#3849

World Rank

#5069

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Israel Frederic. Charo Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Israel Frederic. Charo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The many roles of chemokines and chemokine receptors in inflammation. (2006) (2411)
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis (1998) (2053)
International union of pharmacology. XXII. Nomenclature for chemokine receptors. (2000) (1929)
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. (2006) (1531)
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. (1997) (1128)
The platelet membrane glycoprotein IIb-IIIa complex. (1988) (1092)
Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. (2007) (1002)
Chemokines in the pathogenesis of vascular disease. (2004) (766)
Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. (1994) (715)
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. (1999) (704)
Differential roles of microglia and monocytes in the inflamed central nervous system (2014) (674)
Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) (2000) (632)
Domains specifying thrombin–receptor interaction (1991) (543)
GPIIb-IIIa: The responsive integrin (1991) (516)
Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. (2003) (509)
Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice (2010) (492)
Resolving postoperative neuroinflammation and cognitive decline (2011) (460)
Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. (2011) (427)
Molecular Cloning and Functional Characterization of a Novel Human CC Chemokine Receptor (CCR5) for RANTES, MIP-1β, and MIP-1α* (1996) (419)
CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation (2009) (401)
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction (2013) (401)
Interrelations of platelet aggregation and secretion. (1977) (355)
Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. (1993) (353)
Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis (2001) (346)
Multiple Extracellular Elements of CCR5 and HIV-1 Entry: Dissociation from Response to Chemokines (1996) (343)
Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. (1991) (337)
A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury (2015) (335)
Role of CCR8 and Other Chemokine Pathways in the Migration of Monocyte-derived Dendritic Cells to Lymph Nodes (2004) (331)
Thrombin receptor expression in normal and atherosclerotic human arteries. (1992) (324)
The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood (2012) (311)
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop (1997) (301)
Murine Monocyte Chemoattractant Protein (MCP)-5: A Novel CC Chemokine That Is a Structural and Functional Homologue of Human MCP-1 (1997) (287)
Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. (1993) (273)
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. (2001) (270)
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ TH2 cells (2011) (266)
Additive Roles for MCP-1 and MCP-3 in CCR2-Mediated Recruitment of Inflammatory Monocytes during Listeria monocytogenes Infection1 (2008) (257)
Anti-inflammatory therapeutics for the treatment of atherosclerosis (2011) (256)
The critical role of ocular‐infiltrating macrophages in the development of choroidal neovascularization (2003) (255)
Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction (1999) (249)
Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2−/− Mice: Evidence for Independent Chemokine Functions in Atherogenesis (2008) (246)
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin (1990) (234)
Tissue Factor Is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells* (1997) (233)
Macrophages recruited via CCR2 produce insulin‐like growth factor‐1 to repair acute skeletal muscle injury (2011) (230)
Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. (1999) (227)
CCR2+ monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice (2013) (226)
The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. (1977) (215)
Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells (2012) (213)
Differential Regulation of G-protein-mediated Signaling by Chemokine Receptors* (1996) (212)
Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling (2004) (212)
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation (2015) (205)
Tumor Necrosis Factor-α-converting Enzyme Mediates the Inducible Cleavage of Fractalkine* (2001) (205)
Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. (1991) (194)
The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. (1996) (190)
CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. (2010) (186)
Human Placental Cytotrophoblasts Attract Monocytes and Cd56bright Natural Killer Cells via the Actions of Monocyte Inflammatory Protein 1α (2001) (184)
Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys (2002) (181)
Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis (2006) (177)
Signal Transduction and Ligand Specificity of the Human Monocyte Chemoattractant Protein-1 Receptor in Transfected Embryonic Kidney Cells (*) (1995) (176)
Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE−/− mice (2010) (175)
Inhibition of platelet secretion by an antagonist of intracellular calcium. (1976) (172)
IL-13-Induced Chemokine Responses in the Lung: Role of CCR2 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling1 (2002) (166)
Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection (2001) (163)
Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2−/− Mice1 (2000) (163)
Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: Evidence that directed migration is mediated by βγ dimers released by activation of Gαi-coupled receptors (1997) (162)
Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo (2005) (161)
Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice (2004) (157)
Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix. (1987) (157)
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas (2019) (156)
Chronic expression of monocyte chemoattractant protein‐1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice (2005) (145)
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis (2001) (140)
Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. (1984) (139)
Unique Role of the Chemokine Domain of Fractalkine in Cell Capture (2000) (137)
Organization and Differential Expression of the Human Monocyte Chemoattractant Protein 1 Receptor Gene (1997) (136)
CCR2 Deficiency Decreases Intimal Hyperplasia After Arterial Injury (2002) (134)
Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cells. (1986) (132)
A Mechanism for the Impaired IFN-γ Production in C-C Chemokine Receptor 2 (CCR2) Knockout Mice: Role of CCR2 in Linking the Innate and Adaptive Immune Responses1 (2000) (131)
CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury. (2014) (131)
Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9. (1996) (129)
Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice (2001) (128)
CCR2-Dependent Trafficking of F4/80dim Macrophages and CD11cdim/intermediate Dendritic Cells Is Crucial for T Cell Recruitment to Lungs Infected with Mycobacterium tuberculosis1 (2004) (127)
Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. (1995) (127)
CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. (2003) (124)
Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. (2000) (122)
Human and bovine endothelial cells synthesize membrane proteins similar to human platelet glycoproteins IIb and IIIa. (1985) (119)
Chemokine Fractalkine/CX3CL1 Negatively Modulates Active Glutamatergic Synapses in Rat Hippocampal Neurons (2006) (117)
Evidence that Calcium Regulates Platelet Function (1978) (116)
Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion (2002) (116)
Increased Expression of CCL2 in Insulin-Producing Cells of Transgenic Mice Promotes Mobilization of Myeloid Cells From the Bone Marrow, Marked Insulitis, and Diabetes (2008) (115)
Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. (2001) (115)
The Vitronectin Receptor vfl3 Binds Fibronectin and Acts in Concert with asfll in Promoting Cellular Attachment and Spreading on Fibronectin (1990) (114)
Chemokine Receptor 2 (CCR2) in Atherosclerosis, Infectious Diseases, and Regulation of T‐Cell Polarization (2003) (111)
Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion (1977) (108)
The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1 (1997) (104)
Macrophage Polarization and Insulin Resistance: PPARγ in Control (2007) (103)
Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1 (2002) (98)
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study (2016) (97)
Transient Role for CD1d-Restricted Natural Killer T Cells in the Formation of Atherosclerotic Lesions (2005) (96)
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. (2001) (92)
Phosphorylation by a G protein-coupled kinase inhibits signaling and promotes internalization of the monocyte chemoattractant protein-1 receptor. Critical role of carboxyl-tail serines/threonines in receptor function. (1996) (91)
Dissociation of Chemotaxis from Agonist-induced Receptor Internalization in a Lymphocyte Cell Line Transfected with CCR2B (1997) (91)
Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo1 (2004) (81)
Monocyte recruitment in venous thrombus resolution. (2006) (81)
Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection (2015) (77)
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. (2013) (76)
The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation (2004) (72)
Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. (1999) (71)
Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen. (2002) (69)
Regulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation (2013) (68)
Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in Mice (2002) (65)
Synthesis and expression of the fibroblast fibronectin receptor in human monocytes. (1989) (62)
Macrophage polarization and insulin resistance: PPARgamma in control. (2007) (62)
MCP‐1‐dependent signaling in CCR2−/− aortic smooth muscle cells (2004) (61)
Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor (1998) (60)
The CC Chemokine MCP-1 Stimulates Surface Expression of CX3CR1 and Enhances the Adhesion of Monocytes to Fractalkine/CX3CL1 via p38 MAPK1 (2006) (57)
Impaired lung dendritic cell activation in CCR2 knockout mice. (2004) (57)
CCR2: from cloning to the creation of knockout mice. (1999) (54)
Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection (2010) (49)
Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors. (1997) (49)
CCR2-/- knockout mice revascularize normally in response to severe hindlimb ischemia. (2004) (45)
Zmynd15 Encodes a Histone Deacetylase-dependent Transcriptional Repressor Essential for Spermiogenesis and Male Fertility* (2010) (44)
"Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure. (1992) (44)
CC Chemokine Receptor 2 is Protective Against Noise-Induced Hair Cell Death: Studies in CX3CR1+/GFP Mice (2006) (44)
The Amino-terminal Extracellular Domain of the MCP-1 Receptor, but Not the RANTES/MIP-1α Receptor, Confers Chemokine Selectivity (1996) (41)
CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. (2018) (40)
IL-17–Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin (2017) (38)
Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2 (2004) (38)
The Transcriptional Repressor BLIMP1 Curbs Host Defenses by Suppressing Expression of the Chemokine CCL8 (2014) (32)
CCR 2 + monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx 3 cr 1 deficient mice (2013) (32)
Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice (2006) (29)
Edinburgh Research Explorer common macrophage/DC precursors and the role of CX(3)CR1 in their response to inflammation (2009) (25)
CC Chemokine Receptor-2 Is Not Essential for the Development of Antigen-Induced Pulmonary Eosinophilia and Airway Hyperresponsiveness1 (2000) (25)
CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection (2019) (25)
CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. (2007) (24)
Monocyte-endothelial cell interactions (1992) (23)
Orally administered CCR2 selective inhibitor CCX872-b clinical trial in pancreatic cancer. (2017) (22)
Neutrophil‐dominant experimental autoimmune uveitis in CC‐chemokine receptor 2 knockout mice (2011) (18)
Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis. (2013) (18)
Efficacy of Chemokine Receptor Inhibition in Treating IL-36α–Induced Psoriasiform Inflammation (2019) (18)
Molecular Uncoupling of Fractalkine-mediated Cell Adhesion (1999) (18)
In CCR2-/- mice monocyte recruitment and egress of LDL cholesterol in vivo is impaired. (2003) (17)
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood (2019) (13)
Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer (2015) (13)
Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells. (2004) (13)
Inhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant Model (2008) (12)
CCR 2 antagonist CCX 140-B provides renal and glycemic benefits in diabetic transgenic human CCR 2 knockin mice (2013) (11)
CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS) (2018) (10)
Abstract A107: Inhibition of CCR2 potentiates the checkpoint inhibitor immunotherapy in pancreatic cancer (2016) (10)
MCP-1 in Human Disease (1999) (10)
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications. (2012) (10)
Abstract 5655: Inhibition of CCR2 potentiates checkpoint inhibitor immunotherapy in murine model of pancreatic cancer (2017) (7)
Molecular Cloning and Functional Expression of Murine JE (Monocyte Chemoattractant Protein 1) and Murine Macrophage Inflammatory Protein 1 Receptors (1996) (7)
Correction: Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice (2017) (6)
Molecular approaches to identifying ligand binding and signaling domains of C-C chemokine receptors. (1997) (5)
Interrelations ofPlatelet Aggregation andSecretion (1977) (5)
Blinding the monocytes to protect the heart. (2013) (5)
CX 3 CR1 + CD115 + CD135 + common macrophage/DC precursors and the role of CX 3 CR1 in their response to infl ammation (2009) (5)
IL-13-Induced Inflammation and Remodeling Lung : Role of CCR 2 in the Pathogenesis of IL-13-Induced Chemokine Responses in the (2002) (4)
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study (2019) (4)
Molecular cloning and functional expression of two monocyte (4)
of Platelet Aggregation and Secretion (1977) (4)
from Human Foreskin Microvessels (1984) (3)
Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists. (2014) (3)
Fractalkine and atherosclerosis: a new role for a curious chemokine (2001) (3)
521 Chemokine receptor inhibition as a novel therapeutic approach for psoriasis (2016) (2)
Reduction of Liver Fibrosis by CCR2 Antagonist CCX872 in Murine Models of NASH: 920 (2016) (2)
Chemokine receptors (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (2)
The inhibition of CCR2 to modify the microenvironment in pancreatic cancer mouse model and to support the profiling of the CCR2 inhibitor CCX872-B in patients. (2016) (2)
CORROSION FATIGUE PROPERTIES OF SURGICAL IMPLANT MATERIALS (1973) (2)
Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database (2020) (1)
Effect of C-C Chemokine Receptor 2 (CCR2)knockout on schistosomal egg antigen-elicited granuloma formation and the regional lymphoid response (1998) (1)
Rac1 and CDC42Hs play a critical role in MCP-1-induced chemotaxis (2000) (1)
CCR2 Mediates Hematopoietic Stem/Progenitor Cell Trafficking to Peripheral Tissues after Inflammation (2008) (1)
Abstract B24: Pharmacokinetic and pharmacodynamic profile of the novel, oral and selective CCR2 inhibitor CCX872-B in a Phase 1B pancreatic cancer trial (2015) (1)
IMMU-09. DISRUPTION OF THE CCL2-CCR2 AXIS AUGMENTS THE EFFECTS OF IMMUNE CHECKPOINT INHIBITORS TO SLOW PROGRESSION OF GLIOMAS (2017) (1)
Abstract 5693: Anti-tumor effect of orally available small molecule PD-L1 inhibitors in a murine model of colon adenocarcinoma (2020) (1)
SP042CREATION OF MOUSE MODELS OF COMPLEMENT MEDIATED RENAL DISEASE USING CRISPR-CAS9 TO INTRODUCE KNOWN HUMAN FACTOR H MUTATIONS IN HUMAN C5A-RECEPTOR KNOCK-IN MICE (2016) (0)
P0973ALLOSTERIC C-C CHEMOKINE RECEPTOR TYPE 2 (CCR2) INHIBITION IMPROVES RENAL FUNCTION IN A MURINE MODEL OF DIABETIC NEPHROPATHY (2020) (0)
Abstract 564: Combination therapy of chemokine receptor inhibition plus PD-L1 blockade potentiates antitumor effects in a murine model of breast cancer (2016) (0)
Contents Vol. 45, 2008 (2008) (0)
Independent Induction of Platelet Aggregation and Secretion by Prostaglandin Endoperoxide Analogues and Thromboxane A2-Like Material (1977) (0)
SP004INHIBITION OF THE C5A RECEPTOR BY CCX168 MARKEDLY REDUCES THE THROMBOGENIC POTENTIAL OF SERUM FROM PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME (2015) (0)
IMMU-51. THE COMBINATION OF CCR2 ANTAGONIST AND PD-1 BLOCKADE PROLONGS SURVIVAL IN IMMUNE CHECKPOINT INHIBITOR RESISTANT GLIOMAS (2018) (0)
CCR2 Inhibition Reduces Tumor‐Associated Myeloid‐Derived Suppressor Cells and Unmasks an α‐PD‐1 Effect to Slow Tumor Progression in Checkpoint Inhibitor Resistant Gliomas (2019) (0)
THU0069 Effects of Anti-TNF-Alpha Therapy on the Recruitment and Availability of Osteoclast Precursors in a Model of Rheumatoid Arthritis (2015) (0)
Immunopathology and Infectious Disease Impaired Lung Dendritic Cell Activation in CCR 2 Knockout Mice (2004) (0)
Antagonists of chemokine receptor CCR9 synergize with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis (2020) (0)
Involvement of junctional adhesion molecules in the pathogenesis of experimental autoimmune encephalomyelitis (2014) (0)
Subject Index Vol. 45, 2008 (2008) (0)
691 Neutrophil and C5aR dynamics in hidradenitis suppurativa disease progression (2021) (0)
Mycobacterium tuberculosis Recruitment to Lungs Infected with Dendritic Cells Is Crucial for T Cell dim / intermediateMacrophages and CD 11 c dimCCR 2-Dependent Trafficking of F 4 / 80 (2004) (0)
Research on the Biochemical Basis of Platelet Function (1977) (0)
P0336INHIBITION C-C CHEMOKINE RECEPTOR TYPE 2 (CCR2) ON ACTIVATED KIDNEY PARIETAL EPITHELIAL CELLS REVEALS A NEW THERAPEUTIC APPROACH FOR CHRONIC KIDNEY DISEASES (2020) (0)
Methods for the preparation of platelet aggregation inhibitors (1991) (0)
FP017Critical Equilibrium between CCL2 Secretion and Its Constitutive Re-Uptake by CCR2: An Elegant Mechanism for Regulating CCL2 Levels in the Blood (2019) (0)
Identification of C-C chemokine receptor 1 (CCR1) as the hemofiltrate C-C chemokine (HCC)-1 receptor. (1998) (0)
Abstract CT223: CCX872: Pharmacodynamic study of a potent and selective CCR2 antagonist in human volunteers and plans for phase Ib trial in patients with pancreatic cancer (2015) (0)
Migration during West Nile Virus Infection CCL7 in Monocytosis and Leukocyte Differential Roles of Chemokines CCL2 and (2015) (0)
SaO058CCR2 INHIBITION IMPROVES RENAL FUNCTION & NORMALIZES GLOMERULAR STRUCTURE IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) MODELS (2018) (0)
IMST-15. PHARMACOLOGICAL ANTAGONISM OF CCR2 IMPACTS PROGRESSION OF MURINE GLIOMAS (2016) (0)
Monocyte protein receptors of mammals, with chemoattractant effective (1995) (0)
CurrentsModulation of NMDA-Mediated Synaptic μ Involvement of cAMP-Dependent Protein Kinase in (2015) (0)
University of CC Chemokine Receptor 2 Promotes Recruitment of Myeloid Cells Associated with Insulin Resistance in Non-Alcoholic Fatty Liver Disease (2018) (0)
TO041CCR2 ANTAGONISM REDUCES PROTEINURIA AND GLOMERULAR INJURY IN MURINE MODELS OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) (2017) (0)
220: Fibrinogen/CR3 signaling induces demyelination by promoting Th1 cell differentiation and peripheral macrophage recruitment into the CNS (2013) (0)
Abstract 4952: Transplant Vasculopathy Response in CCR2 and NDST-1 Deficient Mice Aortic Transplant Model After Viral Anti-Inflammatory Chemokine Modulating Protein, M-T7, Treatment (2009) (0)
Abstract 1042: Viral Chemokine Modulating Protein, M-T7, Interrupts Chemokine : Glycosaminoglycan (GAG) Interaction: M-T7 Inhibitory Activity is Dependent upon Y46 and V210 aminoacid residues (2007) (0)
IMMU-05. DISRUPTION OF THE CCR2 CHEMOKINE RECEPTOR PATHWAY OVERCOMES THERAPEUTIC RESISTANCE TO PD-1 BLOCKADE IN MALIGNANT GLIOMA (2019) (0)
Microsoft Word-Z15JBC2010v88 (2010) (0)
Abstract 81: B Lymphocytes Trigger MCP3-Dependent Mobilization of Monocytes and Promote Adverse Ventricular Remodeling After Myocardial Infarction (2012) (0)
Abstract 1361: M-T7, A Viral Chemokine Modulating Protein (vCMP) Inhibits Plaque Growth Through Interruption of Chemokine: GAG Interactions (2006) (0)
Tu1499 Efficacy of a Small Molecule CCR2 Antagonist in Experimental Model of Chronic Pancreatitis (2016) (0)
Mice: The Role of Mast Cells - / - CCR2Bronchial Hyperreactivity in Normal But Not Mediates Cockroach Allergen-Induced Monocyte Chemoattractant Protein-1 (1999) (0)
Chemokine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (0)
FP240CCR2 INHIBITION IMPROVES RENAL FUNCTION IN MURINE MODELS OF CHRONIC KIDNEY DISEASE (2019) (0)
Adulthood Present on Microglia from Embryonic The Fractalkine Receptor but Not CCR 2 (2011) (0)
Evidence for a Central Role for Calcium Ions in Regulation of Platelet Function (1977) (0)
HyperresponsivenessPulmonary Eosinophilia and Airway for the Development of Antigen-Induced CC Chemokine Receptor-2 Is Not Essential (2000) (0)
CCR2 Mediates Hematopoietic Stem and Progenitor Cell Trafficking to Inflammation Sites to Enhance Organ Repair. (2009) (0)
The Platelet Membrane Glycoprotein IIb-III a Complex: Member of a Superfamily of Adhesive Protein Receptors (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Israel Frederic. Charo?

Israel Frederic. Charo is affiliated with the following schools:

Israel Frederic. Charo's Academic­Influence.com Rankings

Why Is Israel Frederic. Charo Influential?

Israel Frederic. Charo's Published Works

Published Works

What Schools Are Affiliated With Israel Frederic. Charo?

Israel Frederic. Charo's AcademicInfluence.com Rankings